- Home
- CANF vs RMCF Comparison
CANF vs RMCF Comparison
Compare CANF & RMCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | RMCF |
|---|---|---|
| Founded | 1994 | 1981 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 17.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CANF | RMCF |
|---|---|---|
| Price | $0.20 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | ★ 10.0M | 37.3K |
| Earning Date | 02-03-2026 | 10-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $560,000.00 | ★ $29,988,000.00 |
| Revenue This Year | $461.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.09 |
| 52 Week Low | $0.17 | $1.12 |
| 52 Week High | $2.33 | $3.18 |
Technical Indicators
Market Signals| Indicator | CANF | RMCF |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 60.56 |
| Support Level | $0.17 | $1.77 |
| Resistance Level | $0.27 | $1.99 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 21.60 | 79.98 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.